Glutathione S-transferase polymorphisms: Susceptibility to migraine without aura

European Neurology

Volumn 49, Issue 4, 2003, Pages 218-222

  Kusumi, Masayoshi ^a,c   Ishizaki, K ^a   Kowa, H ^a   Adachi, Y ^a   Takeshima, T ^a   Sakai, F ^b   Nakashima, K ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY   (Japan)

^c TOTTORI UNIVERSITY   (Japan)

Author keywords

Genetic association study; Migraine; Risk factor; Smoking

Indexed keywords

GLUTATHIONE TRANSFERASE;

ADULT; AGE; AMINO ACID SUBSTITUTION; ARTICLE; CIGARETTE SMOKING; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HEADACHE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PRIORITY JOURNAL; RISK; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

ADULT; ALLELES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING;

EID: 0037963084     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070187     Document Type: Article

References (22)

1. Montagna P: Molecular genetics of migraine headaches: A review. Cephalalgia 2000;20:3-14.
2. 2+ channel gene CACNL1A4. Cell 1996;87:543-552.
3. Ferrari MD: Migraine. Lancet 1998;351:1043-1051.
4. 2 receptor (DRD2) NcoI alleles. Neurology 1997;49:201-206.
5. Kowa H, Yasui K, Takeshima T, Urakami K, Sakai F, Nakashima K: The homozygous C677T mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine. Am J Med Genet 2000;96:762-764.
6. Paterna S, di Pasquale P, D'Angelo A, Seidita G, Tuttolomondo A, Cardinale A, Maniscalchi T, Follone G, Giubilato A, Tarantello M, Licata G: Angiotensin-converting enzyme gene deletion polymorphism determines an increase in frequency of migraine attacks in patients suffering from migraine without aura. Eur Neurol 2000;43:133-136.
7. Terwindt GM, Ophoff RA, van Eijk R, Vergouwe MN, Haan J, Frants RR, Sandkuijl LA, Ferrari MD: Involvement of the CACNA1A gene containing region on 19p13 in migraine with and without aura. Neurology 2001;56:1028-1032.
8. Gervil M, Ulrich V, Kaprio J, Olesen J, Russell MB: The relative role of genetic and environmental factors in migraine without aura. Neurology 1999;53:995-999.
9. Mannervik B: The isozymes of glutathione transferase. Adv Enzymol Relat Areas Mol Biol 1985;57:357-417.
10. Hayes JD, Strange RC: Potential contribution of the glutathione S-transferase supergene family to resistance to oxidative stress. Free Radic Res 1995:22:193-207.
11. Harris MJ, Coggan M, Langton L, Wilson SR, Board PG: Polymorphism of the Pi class glutathione S-transferase in normal populations and cancer patients. Pharmacogenetics 1998;8:27-31.
12. Katoh T, Kaneko S, Takasawa S, Nagata N, Inatomi H, Ikemura K, Itoh H, Matsumoto T, Kawamoto T, Bell DA: Human glutathione S-transferase P1 polymorphism and susceptibility to smoking related epithelial cancer, oral, lung, gastric, colorectal and urothelial cancer. Pharmacogenetics 1999;9:165-169.
13. Katoh T, Kaneko S, Kohshi K, Munaka M, Kitagawa K, Kunugita N, Ikemura K, Kawamoto T: Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and oral cavity cancer. Int J Cancer 1999;83:606-609.
14. Chen H, Sandler DP, Taylor JA, Shore DL, Liu E, Bloomfield CD, Bell DA: Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet 1996;347:295-297.
15. Strange RC, Matharoo B, Faulder GC, Jones P, Cotton W, Elder JB, Deakin M: The human glutathione S-transferases: A case-control study of the incidence of the GST1 0 phenotype in patients with adenocarcinoma. Carcinogenesis 1991;12:25-28.
16. Mattsson P, Bjelfman C, Lundberg PO, Rane A: Cytochrome P450 2D6 and glutathione S-transferase M1 genotypes and migraine. Eur J Clin Invest 2000;30:367-371.
17. Headache Classification Committee of the International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(suppl 7):1-96.
18. Menegon A, Board PG, Blackburn AC, Mellick GD, Le Couteur DG: Parkinson's disease, pesticides, and glutathione transferase polymorphisms. Lancet 1998;352:1344-1346.
19. Michael A, Muhlbauer R, Hengstler J, Jager E, Fuchs J, Winkler L, Oesch F: A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Anal Biochem 1996;236:184-186.
20. Payne TJ, Stetson B, Stevens VM, Johnson CA, Penzien DB, Van Dorsten B: The impact of cigarette smoking on headache activity in headache patients. Headache 1991;31:329-332.
21. Christiansen I, Thomsen LL, Daugaard D, Ulrich V, Olesen J: Glyceryl trinitrate induces attacks of migraine without aura in sufferers of migraine with aura. Cephalalgia 1999;19:660-667.
22. Messina ES, Tyndale RF, Sellers EM: A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. J Pharmacol Exp Ther 1997;282:1608-1614.